Eucrisa — Point32Health
Topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients age ≥ 3 months
Preferred products
- pimecrolimus cream
- tacrolimus ointment
- topical corticosteroids
Initial criteria
- The patient has had a trial of a Step-1 medication (pimecrolimus cream OR tacrolimus ointment OR topical corticosteroids) as evidenced by physician’s documented use OR previous paid claim under the prescription benefit administered by the plan
- OR the patient has a physician documented contraindication or intolerance to all of the Step-1 medications